October 2016 - Biowebspin | Biowebspin
Logo Biowebspin

Archives October 2016 - Biowebspin

From Gutenberg to Open Science: An Unfulfilled Odyssey

From Gutenberg to Open Science: An Unfulfilled Odyssey

Biowebspin, October 28th, 2016 From Gutenberg to Open Science: An Unfulfilled Odyssey by Chris R. Triggle, David J. Triggle in Drug development research, 2016 With the almost global availability of the Internet comes the expectation of universal accessibility to knowledge, including scientific knowledge-particularly that generated by public funding. Currently this is not the case. In this Commenta... »

Understanding healthcare innovation systems: the Stockholm region case

Understanding healthcare innovation systems: the Stockholm region case

  Biowebspin, October 25th, 2016 Understanding healthcare innovation systems: the Stockholm region case by Lisa-Marie Larisch, Isis Amer-Wåhlin, Patrik Hidefjäll, in Journal of Health Organization and Management, 2016 Purpose There is an increasing interest in understanding how innovation processes can address current challenges in healthcare. The purpose of this case study was to analyze the wide... »

Collaboration Is Key to Innovation in Biotechnology

Collaboration Is Key to Innovation in Biotechnology

  Biowebspin, October 21th, 2016 Collaboration Is Key to Innovation in Biotechnology by Donald Johnston in Bioprocess International, 2016 A new report from Thomson Reuters shows that innovation in biotechnology declined slightly in 2015, and biotech is the only one of a dozen worldwide industries examined to show that kind of decline (1). To measure innovation, compilers used metrics such as paten... »

Redefining responsible research and innovation for the advancement of biobanking and biomedical research

Redefining responsible research and innovation for the advancement of biobanking and biomedical research

  Biowebspin, October 17th, 2016 Redefining responsible research and innovation for the advancement of biobanking and biomedical research by Helen Yu in J Law Biosci, 2016 One of the core objectives of responsible research and innovation (RRI) is to maximize the value of publicly funded research so that it may be returned to benefit society. However, while RRI encourages innovation through societa... »

Innovation without corporate R&D? An analysis of the Italian case and implications for policy

Innovation without corporate R&D? An analysis of the Italian case and implications for policy

  Biowebspin, October 14th, 2016 Innovation without corporate R&D? An analysis of the Italian case and implications for policy by Pietro MONCADA-PATERNÒ-CASTELLO and Nicola GRASSANO, 2016 This paper analyses the status of private R&D investment in Italy based on a collection of recent evidences and indicates possible policy actions to boost private R&D investment. Our analysis relies ... »

Women Business Leaders in Biotech and Hi-Tech, and Related Industry Cluster Factors

Women Business Leaders in Biotech and Hi-Tech, and Related Industry Cluster Factors

  Biowebspin, October 10th, 2016 Women Business Leaders in Biotech and Hi-Tech, and Related Industry Cluster Factors by Jessica White, San Jose State University, 2016 Women entrepreneurs are on the rise and their numbers have grown at one and a half times the rate of small enterprises generally over the last 15 years. In spite of this, women are underrepresented in the fields of science, technolog... »

Fund my treatment!: A call for ethics-focused social science research into the use of crowdfunding for medical care

Fund my treatment!: A call for ethics-focused social science research into the use of crowdfunding for medical care

  Biowebspin, October 03th, 2016 Fund my treatment!: A call for ethics-focused social science research into the use of crowdfunding for medical care by Donrich W. Jordaan, in Soc Sci Med., 2016 Crowdfunding involves raising money from large groups of individuals, often through the use of websites dedicated to this purpose. Crowdfunding campaigns aimed at raising money to pay for expenses related t... »